Trulieve files registration statement – Jun 30, 2025

Trulieve Cannabis Corp, a prominent cannabis company in the U.S., recently announced the filing of a shelf registration statement on Form S-3 with the United States Securities and Exchange Commission. This registration statement, which was submitted on June 30, 2025, aims to register a base shelf prospectus, providing the company with increased flexibility for potential future financing activities. It’s essential to note that there are currently no plans for Trulieve to offer or sell any securities under this registration.

Upon acceptance by the SEC, the registration statement is anticipated to become effective. Once this occurs, Trulieve will have the option to sell securities based on the terms outlined in the prospectus supplement. Although a registration statement for these securities has been filed with the SEC, it has yet to become effective. Therefore, any sale of securities or acceptance of offers to purchase must await the registration statement’s effectiveness. This press release is not an invitation to purchase securities, nor does it solicit any offers to acquire them.

Trulieve is committed to transparency, and as such, it has taken the necessary steps to register these securities properly. Interested parties are encouraged to review the prospectus in the registration statement and other relevant documents filed with the SEC to obtain comprehensive information about the company and any potential offerings. These documents are available for free on the SEC website, EDGAR.

Trulieve is a leading cannabis company operating in multiple states in the U.S., including Arizona, Florida, and Pennsylvania. Through its innovative product offerings and strategic distribution network, the company aims to enhance customer experiences and expand accessibility to cannabis for both patients and recreational users. Trulieve’s presence in key markets and its commitment to product quality and customer satisfaction position the company for sustained growth and expansion in the future.

For those seeking more information about Trulieve, including its market performance, product portfolio, and growth strategies, additional details can be found on the company’s official website. For investors looking to connect with Trulieve’s Investor Relations department, they can reach out to Christine Hersey, the Vice President of Investor Relations, using the provided contact information. Media inquiries can be directed to Phil Buck, the Corporate Communications Manager, who can also be reached through the contact information provided.

In conclusion, Trulieve’s registration statement filing is a significant development that underscores the company’s commitment to financial transparency and regulatory compliance. As a key player in the cannabis industry, Trulieve continues to prioritize innovation, quality, and customer satisfaction as it looks towards a future of sustained growth and market expansion.